1. Home
  2. TCBK vs GENB Comparison

TCBK vs GENB Comparison

Compare TCBK & GENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo TriCo Bancshares

TCBK

TriCo Bancshares

HOLD

Current Price

$49.12

Market Cap

1.6B

Sector

Finance

ML Signal

HOLD

GENB

Generate Biomedicines Inc. Common Stock

N/A

Current Price

$12.74

Market Cap

1.7B

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
TCBK
GENB
Founded
1975
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
1995
N/A

Fundamental Metrics

Financial Performance
Metric
TCBK
GENB
Price
$49.12
$12.74
Analyst Decision
Buy
Strong Buy
Analyst Count
5
6
Target Price
$53.80
$23.20
AVG Volume (30 Days)
100.2K
321.8K
Earning Date
04-23-2026
05-07-2026
Dividend Yield
2.84%
N/A
EPS Growth
6.94
N/A
EPS
3.70
N/A
Revenue
$53,445,000.00
N/A
Revenue This Year
$12.03
N/A
Revenue Next Year
$4.47
$16.58
P/E Ratio
$13.69
N/A
Revenue Growth
4.12
N/A
52 Week Low
$37.80
$11.00
52 Week High
$53.18
$14.21

Technical Indicators

Market Signals
Indicator
TCBK
GENB
Relative Strength Index (RSI) 50.27 52.76
Support Level $48.06 $11.39
Resistance Level $51.15 $13.40
Average True Range (ATR) 1.07 0.70
MACD -0.02 0.06
Stochastic Oscillator 28.81 73.45

Price Performance

Historical Comparison
TCBK
GENB

About TCBK TriCo Bancshares

TriCo Bancshares is a California corporation organized to act as a bank holding company for Tri Counties Bank. The Bank is a California-chartered bank that is engaged in the general commercial and retail banking business in California counties. The Bank provides a breadth of personal, small business, and commercial financial services, including accepting demand, savings and time deposits and making small business, commercial, real estate, and consumer loans, as well as a range of treasury management services and other customary banking services including safe deposit boxes at some branches. The company's primary source of revenue is the net interest income.

About GENB Generate Biomedicines Inc. Common Stock

Generate Biomedicines Inc is a clinical-stage generative biology company pioneering the AI revolution in biotechnology and drug design and development. The company's single operating segment is engaged in the field of generative biology by using machine learning for drug discovery and development through the programming of novel protein therapeutics. Its product candidates include: GB-0895, GB-4362, and GB-5267. Through the company's Generate Platform, it can generate medicines on demand across multiple therapeutic modalities with unprecedented speed representing a fundamental shift in drug discovery.

Share on Social Networks: